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rboland@criba.edu.arAbstract17b-Estradiol (E2) protects several non-reproductive tissues from apoptosis, including
skeletal muscle. We have shown that E2 at physiological concentrations prevented apoptosis
induced by H2O2 in C2C12 skeletal myoblasts. As we also demonstrated the presence of
estrogen receptors inmitochondria, the present workwas focused on the effects of E2 on this
organelle. Specifically, we evaluated the actions of E2 on the mitochondrial permeability
transition pore (MPTP) by the calcein-acetoxymethylester/cobalt method using fluorescence
microscopy and flow cytometry. Pretreatment with E2 prevented MPTP opening induced by
H2O2, which preceded loss of mitochondrial membrane potential. In addition, it was
observed that H2O2 induced translocation of Bax to mitochondria; however, in the presence
of the steroid this effect was abrogated suggesting that members of the Bcl-2 family may be
regulated by E2 to exert an antiapoptotic effect. Moreover, E2 increased mitochondrial
manganese superoxide dismutase protein expression and activity, as part of a mechanism
activated by E2 that improved mitochondrial performance. Our results suggest a role of E2 in
the regulation of apoptosis with a clear action at the mitochondrial level in C2C12 skeletal
myoblast cells.Key Words
" 17b-estradiol
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" MnSODJournal of Endocrinology
(2013) 216, 331–341IntroductionThe steroid hormone 17b-estradiol (E2) plays an import-
ant role in development, cell growth, and differentiation,
acting through both genomic and non-genomic
mechanisms (De Feo 1996, Bjornstrom & Sjoberg 2005).
It is generally accepted that the majority of the hormone
effects are mediated by two estrogen receptors (ERs),
namely ERa and ERb (Evans 1988, Tsai & O’Malley 1994,
Beato et al. 1996, Pettersson et al. 2000, Hall et al. 2001,
Hewitt & Korach 2002). The actions of E2 have been
typically linked to reproductive functions. However,
during the last decade it has been shown that practicallyevery animal cell/tissue/organ system responds to the
hormone to some extent (reviewed in Vasconsuelo et al.
(2011)). One of the reasons for this opening out in the
non-conventional estrogen actions was the finding of ER
in non-classical tissues and with non-classical intra-
cellular localizations. For example, the presence of ERs
in mitochondria of C2C12 skeletal myoblasts has
previously been shown (reviewed in Vasconsuelo et al.
(2011)). Although the localization of mitochondrial ERs
is well established, allowing one to envision an influence
of E2 upon mitochondrial functions, the physiological
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Mitochondria are vital organelles, mainly involved in
cellular energy production and regulation of programmed
cell death (apoptosis). In previous studies, it was shown
that E2 at physiological concentrations prevented apop-
tosis in skeletal myoblasts in an ER-dependent fashion.
Typical changes of apoptosis such as nuclear fragmenta-
tion, cytoskeleton disorganization, mitochondrial reorga-
nization/dysfunction, and cytochrome c release induced
by H2O2, were abolished when cells were previously
exposed to E2 (Vasconsuelo et al. 2008). Likewise, we
demonstrated that E2 exerts its antiapoptotic effect
through ERs with non-classical localization involving
MAPKs, HSP27, and the survival PI3K/Akt pathway,
which phosphorylates and inactivates proapoptotic
members of the Bcl-2 family (Vasconsuelo et al. 2008,
2010, Ronda et al. 2010). The mitochondrial protein
cytochrome c plays a key role in apoptosis (reviewed by
Jiang & Wang (2004)). This soluble protein is localized in
the intermembrane space and is loosely attached to the
surface of the inner mitochondrial membrane. In response
to a variety of apoptosis-inducing agents, cytochrome c is
released from mitochondria to the cytosol, an event that is
considered the key regulatory step irreversibly committing
cells to apoptosis (Liu et al. 1996, Reed 1997, Kumarswamy
& Chandna 2009). Several models have been proposed to
explain the mechanism of cytochrome c release from
mitochondria, such as the loss of integrity or/and an
increment of permeability of the outer mitochondrial
membrane (Crompton et al. 1999, Green & Kroemer 2004).
Thus, the increase of outer mitochondrial membrane
permeability is a crucial event in apoptosis (Desagher &
Martinou 2000, Tsujimoto 2003). Nevertheless, the
mechanism(s) responsible for this augmented permeabili-
zation is/are not well established. It is known that
members of Bcl-2 family are involved in this process
(Antignani & Youle 2006). Indeed, Bax is found in the
cytosol of most normal healthy tissues, which indicates
that the protein is kept in an inactive form in the cells. In
apoptotic cells or when Bax is overexpressed, it is targeted
to mitochondrial membranes, where the protein triggers
cytochrome c release, leading to apoptosis (reviewed in
Sharpe et al. (2004)). Another mechanism postulated,
which results in outer mitochondrial membrane permea-
bilization, involves the mitochondrial permeability tran-
sition pore (MPTP), which generally is associated with
mitochondrial membrane potential (DJm) functionality
(Armstrong 2006). The exact molecular nature of the
MPTP is still a matter of debate, although this pore ishttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLYconsidered a large multiprotein complex, primarilycomposed of the adenine nucleotide transporter (ANT),
cyclophilin D, and voltage-dependent anion channel
(VDAC, also called porin) that can interact with several
other proteins (Kroemer et al. 1998, Crompton 1999).
Under normal physiological conditions, the mito-
chondrial inner membrane is nearly impermeable to all
ions. However, under stress conditions, the MPTP can
open in the mitochondrial inner membrane allowing the
free passage of solutes with molecular masses up to
1500 Da (Halestrap et al. 2002). Its opening results in the
disruption of the inner membrane permeability barrier
and swelling of the matrix space. As the inner mito-
chondrial membrane has a surface area several times that
of the outer mitochondrial membrane, swelling of the
matrix space results in rupture of the outer membrane
and, in consequence, the release of mitochondrial
components such as cytochrome c occurs. It has been
shown that members of Bcl-2 family could regulate the
MPTP (Reed & Kroemer 1998).
Mitochondria are especially sensitive to reactive
oxygen species (ROS). Of importance for our studies,
under high levels of ROS MPTP can be activated (Petronilli
et al. 1994). Generally, cells are equipped with antioxidant
enzymes that can prevent these and other effects of ROS.
Thus, superoxide anion is dismutated by the enzyme
superoxide dismutase (SOD), to yield H2O2, which is
eliminated by glutathione peroxidase and catalase
(Bhuyan & Bhuyan 1978). There are three isoforms of
SOD, the cytosolic-CuZnSOD (SOD1), mitochondrial
manganese SOD (MnSOD), and the extracellular SOD
(ecSOD). It has been reported that E2 can preserve
mitochondrial function by regulating mitochondrial
antioxidant enzymes in human lens and cerebral vessels
(Stirone et al. 2005, Gottipati & Cammarata 2008) and that
MnSOD overexpression prevents apoptosis (Manna et al.
1998, Fujimura et al. 1999).
Skeletal myoblasts are essential for the normal growth,
repair, and regeneration of differentiated adult skeletal
fibers. C2C12 cells resemble these activated satellite cells.
Moreover, apoptosis increases significantly with age
affecting satellite cells and contributing to sarcopenia
( Jejurikar & Kuzon 2003). Therefore, knowledge of the
mechanism underlying the antiapoptotic action of E2 in
C2C12 myoblasts is relevant to understand the hormone
protective effects on satellite skeletal cells. We propose
that E2 protects skeletal myoblasts through a direct
mitochondrial action. To test this hypothesis, the present
work investigates the mitochondrial effects of E2, which in
turn regulates apoptosis in C2C12 skeletal myoblasts. It isPublished by Bioscientifica Ltd.
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These findings have implications in the prevention and
management of sarcopenia, including development of
pharmacologic inhibitors of specific mitochondrial targets
to block apoptosis and reduce the loss of satellite cells.Materials and methods
Material
Anti-cytochrome c oxidase (COX) IV antibody (1:1000)
was purchased from Cell Signaling Technology, Inc.
(Danvers, MA, USA). Anti-SOD2 (1:1000) was from Santa
Cruz Biotechnology, Inc. Anti-beta tubulin (1:10 000) and
anti-Bax (1:1000 for western blot analysis and
1:50 for immunocytochemistry) antibodies were obtained
from Thermo Fisher Scientific, Inc. (Rockford, IL, USA).
MitoTracker Red (MitoTracker Red CMXRos) dye and Alexa
Fluor 488-conjugated anti-rabbit secondary antibody (1:200)
were provided by Molecular Probes (Eugene, OR, USA). E2
and fulvestrant (ICI 182 780) were from Sigma–Aldrich.
Superoxide Dismutase Assay Kit II was from Calbiochem
Corp. (La Jolla, CA, USA). Calcein-easter-acetoxymethylester
(AM) was purchased from Invitrogen. 5,50,6,60-Tetrachloro-
1,1 0,3,3 0-tetraethylben-zimidazolylcarbocyanine iodide
( JC-1) was obtained from Becton Dickinson Biosciences
(San Jose, CA, USA). The ECL blot detection kit and protein
molecular weight markers were provided by Amersham.
All the other reagents used were of analytical grade.Cell culture and treatment
C2C12 murine skeletal myoblasts obtained from American
Type Culture Collection (Manassas, VA, USA) were
cultured in growth medium (DMEM) supplemented with
10% heat-inactivated (30 min, 56 8C) fetal bovine serum,
1% nistatine, and 2% streptomycin. These highly myo-
genic cells have been widely used to study muscle
functions (Burattini et al. 2004, Vasconsuelo et al. 2008,
Pronsato et al. 2012). Cells were incubated at 37 8C in a
humid atmosphere of 5% CO2 in air. Cultures were
passaged every 2 days with fresh medium. The treatments
were performed with 70–80% confluent cultures
(120 000 cells/cm2) in medium without serum for
30 min. During this preincubation, cells were exposed to
1 mM fulvestrant in specific experiments. Then 10K8 M E2
or vehicle 0.001% isopropanol (control) was added
w120 min before induction of apoptosis with hydrogen
peroxide (H2O2) at the times indicated (ranging fromhttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLY30 min to 4 h). This time and concentration range of theoxidant has been previously used to study apoptosis in
C2C12 cells (Jiang et al. 2005, Vasconsuelo et al. 2008, Siu
et al. 2009, Pronsato et al. 2012). H2O2 was diluted in
culture medium without serum at a final concentration of
0.5 mM in each assay. After treatments, cells were lysed
using a buffer composed of 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 0.2 mM Na2VO4, 2 mM EDTA, 25 mM NaF,
1 mM phenylmethylsulfonyl fluoride (PMSF), 1% NP40,
20 mg/ml leupeptin, and 20 mg/ml aprotinin. Protein
concentration was estimated by the method of Bradford
(1976), using BSA as standard. For microscopical assays,
cells were cultured in chamber slides.Western blot analysis
Protein samples (25 mg) were mixed with sample buffer
(400 mM Tris–HCl (pH 6.8), 10% SDS, 50% glycerol,
500 mM dithiothreitol (DTT), and 2 mg/ml bromophenol
blue), boiled for 5 min, and resolved by 10–12%
SDS–PAGE according to the method of Laemmli (1970).
Fractionated proteins were electrotransferred to polyviny-
lidene fluoride membranes (Immobilon-P; PVDF) and
then blocked for 1 h at room temperature with 5% non-
fat dry milk in PBS containing 0.1% Tween-20 (PBS-T).
Blots were incubated overnight with the appropriate
dilution of the primary antibodies: anti-Bax, anti-
COX IV, and anti-b-tubulin using anti-rabbit secondary
antibodies for all of them; anti-SOD2 (MnSOD) with
anti-mouse secondary antibody. The membranes were
repeatedly washed with PBS-T before incubation with
HRP-conjugated secondary antibodies. The ECL blot
detection kit was used as described by the manufacturer
to visualize reactive products. Relative migration of
unknown proteins was determined by comparison with
molecular weight markers. When needed, membranes
were stripped with stripping buffer (62.5 mM Tris–HCl
(pH 6.7), 2% SDS, 50 mM b-mercaptoethanol), washed
with PBS containing 1% Tween-20 and then blocked for
1 h with 5% non-fat dry milk in PBS-T. The blots were then
incubated with the corresponding primary antibody.
After several washings with PBS-T, membranes were
incubated with secondary antibodies. The correspon-
ding immunoreactive bands were developed as before.Subcellular fractionation
C2C12 cells were scrapped and homogenized in ice-cold
Tris–EDTA-sucrose buffer (50 mM Tris–HCl (pH 7.4),Published by Bioscientifica Ltd.
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and 20 mg/ml trypsin inhibitor) using a Teflon-glass
hand homogenizer. Total homogenate free of debris was
used in order to isolate the different fractions. Nuclear
pellet was obtained by centrifugation at 800 g for
15 min at 4 8C. The supernatant was further centrifuged
at 10 000 g for 30 min at 4 8C to yield the mitochondrial
pellet. The remaining supernatant was called cytosolic
supernatant. Pellets were resuspended in lysis
buffer (50 mM Tris–HCl (pH 7.4), 150 mM NaCl,
0.2 mM Na2VO4, 2 mM EDTA, 25 mM NaF, 1 mM
PMSF, 20 mg/ml leupeptin, and 20 mg/ml aprotinin).
Protein concentration of the fractions was estimated by
the method of Bradford (1976), using BSA as standard
and western blot assays were performed as described
before. Cross contamination between fractions was
assessed by western blot analysis using anti-COX IV as
mitochondrial marker.Measurement of SOD activity
Two million cells were lysed in 20 mmol/l HEPES buffer
containing 1 mmol/l EGTA, 210 mmol/l mannitol, and
70 mmol/l sucrose to measure the enzyme activity using
Superoxide Dismutase Assay Kit II according to the
manufacturer’s directions. To obtain mitochondrial SOD,
the lysates were centrifugated at 800 g for 15 min at 4 8C
and the supernatant at 10 000 g for 30 min at 4 8C. Then,
the mitochondrial pellets were suspended in the cold
buffer used before. This suspension (10 ml) was mixed with
200 ml of radical detector (tetrazolium salt). The reaction
was incubated at room temperature for 20 min and read
at 450 nm using a Genius plate reader from Tecan
(Mannedorf, Switzerland). One unit of SOD activity is
defined as the amount of enzyme needed to exhibit
50% dismutation of the superoxide radical.Immunocytochemistry
Coverslips with adherent cells were stained with Mito-
Tracker Red, prepared in DMSO and then added to the cell
culture medium at a final concentration of 1 mmol/l. After
15–30 min of incubation at 37 8C in darkness, cells were
washed with PBS (pH 7.4, 8 g/l NaCl, 0.2 g/l KCl,
0.24 g/l KH2PO4, and 1.44 g/l Na2HPO4) and fixed with
methanol at K20 8C for 30 min. After fixation, non-
specific sites were blocked for 1 h with PBS 5% BSA. Cells
were incubated with appropriate primary antibodies over-
night at 4 8C. The primary antibodies were recognized byhttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLYfluorophore-conjugated secondary antibodies. Finally, thestained cells were analyzed with a conventional fluor-
escence microscope (NIKON Eclipse Ti-S equipped with
standard filter sets to capture fluorescent signals,
and images were collected using a digital camera).
The specificity of the labeling techniques was proven by
the absence of fluorescence when the primary or
secondary antibodies were omitted.Measurement of MPTP opening
We assessed the MPTP opening using the calcein-
AM/cobalt method according to Petronilli et al. (1999).
Briefly, 70–80% confluent cultures in 10 cm (flow cyto-
metry) or 3 cm (microscopy) plates were loaded for 30 min
with 1 mM calcein-AM at 37 8C in DMEM media. We
quenched the cytosolic and nuclear calcein fluorescence
using 1 mM CoCl2. After attainment of quenching, cells
were washed twice with warm DMEM without serum.
Following the corresponding treatments, cells were
examined by digital fluorescence microscopy. Image
quantification was performed by measuring the fluor-
escence intensity profiles (in arbitrary units) using the
IMAGE J program 1.46. Additionally, the loaded cells were
trypsinized, harvested, and analyzed in a FACS Calibur
flow cytometer (excitation wavelength of 488 nm).Measurement of mitochondrial membrane potential
(DJm)
Cellular DJm was determined using the JC-1 mito-
chondrial transmembrane potential detection kit from
Becton-Dickinson Biosciences. JC-1 is a cationic fluor-
escent dye probe (green as monomer/red as aggregates)
that accumulates in mitochondria in a potential-
dependent manner. Cells with functional mitochondria
incorporate JC-1 leading to the formation of JC-1
aggregates, which show a red spectral shift resulting in
higher levels of red fluorescence emission measured in the
red (FL-2 channel) and green monomers (detectable in FL1
channel). Cells with collapsed mitochondria contain
mainly green JC-1 monomers. The assays were performed
with 70–80% confluent cultures in 10 cm plates. After
treatments, cells were trypsinized, harvested, and
incubated with JC-1 probe in 5 ml polystyrene round-
bottom tubes according to the manufacturer’s specifi-
cations, for 15 min at 37 8C. Cells were then washed twice
and analyzed in a FACS Calibur flow cytometer (excitation
wavelength of 488 nm).Published by Bioscientifica Ltd.
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216 :3 335AUTHOR COStatistical analysisResults are shown as meansGS.D. of not less than three
independent experiments. Statistical differences among
groups were performed using ANOVA followed by a
multiple comparison post hoc test (Tukey 1953). The
statistical significance of data was determined as P!0.05.Control
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E2 inhibits MPTP opening in C2C12 skeletal myoblasts
Mitochondria, which play a crucial role in apoptosis,
release several apoptosis-inducing factors into the cyto-
plasm. This process requires the increase of outer
mitochondrial membrane permeability, which probably
depends on the activation of MPTP. To evaluate the effects
of E2 on MPTP function in C2C12 cells, we used a cobalt-
quenched calcein-AM method. Calcein-AM is an anionic,
esterified fluorochrome that enters the cells freely and
labels cytoplasmic as well as mitochondrial regions
following esterase removal of the AM group. Because
cobalt ions enter to the cytoplasm but do not readily pass
through the mitochondrial membrane, mitochondria can
be specifically identified by the cobalt quenching of
cytoplasmic, but not mitochondrial, calcein fluorescence.
In consequence, MPTP opening can be recognized by a
decrease of mitochondrial calcein fluorescence (Petronilli
et al. 1999).
C2C12 cell cultures, loaded with calcein-AM/CoCl2,
were incubated with E2 or vehicle isopropanol (control)
before induction of apoptosis with H2O2 (4 h), following
the experimental protocols indicated in each set of
experiments. The cells were then analyzed by microscopy
and flow cytometry as described in Materials and methods.
As shown in Fig. 1A and B by microscopical analysis, the
treatment with H2O2 resulted in a significant decrease of
calcein fluorescence intensity due to CoCl2 quenching as a
result of MPTP opening. However, when the cells were
previously treated with E2, the fluorescence was dimin-
ished to a lesser extent, implying a protective role of
estrogen over this pore. These data were confirmed by flowFigure 1
E2 prevents H2O2-induced MPTP opening in C2C12 skeletal myoblasts. Cells
loaded with calcein-AM/CoCl2 were incubated with 10
K8 M E2 or vehicle,
before the induction of apoptosis with 0.5 mMH2O2 for 4 h, as described in
Materials and methods. MPTP opening was analyzed using a fluorescence
microscope and flow cytometry. (A and B) Microscopy analysis. (C) Flow
cytometry analysis. Treatment with H2O2 leads to a pronounced decrease in
mitochondrial calcein fluorescence while pretreatment with E2 conduces to
a recovery of this signal, indicating the prevention of MPTP aperture.
Representative photographs of each condition are shown. Experiments
were repeated at least three times with essentially identical results. Image
quantification was performed using the ImageJ 1.46 program. AveragesG
S.D. are given. *P!0.05 with respect to the control and #P!0.05 with
respect to H2O2. FL-1: FL-1 channel that detects green fluorescence.
Full colour version of this figure available via http://dx.doi.org/10.1530/
JOE-12-0486.
Published by Bioscientifica Ltd.
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with H2O2 led to a reduction in mitochondrial calcein
fluorescence, evidenced by a decreased FL-1 signal
compared with control (from 87.5G12.6 vs 28G10.2%
respectively). However, in the presence of the steroid,
H2O2 was unable to induce this loss of mitochondrial
fluorescence implying that E2 prevented MPTP activation.
Accordingly, when the cells were pretreated with E2 and
then with the apoptotic agent, the percentage of cells with
green fluorescence (79G17%) was near to the control
condition (87G12.6%) (Fig. 1C).
DJm loss can be associated with the opening of
MPTP (Armstrong 2006). In agreement with the operation
of this mechanism, we found by flow cytometry and
using the JC-1 probe that after 4 h of treatment withFigure 2
MPTP opening precedes mitochondrial membrane potential loss in C2C12
skeletal myoblasts. C2C12 cells loaded with JC-1 or calcein-AM/CoCl2 were
incubated with 0.5 mM H2O2 during the time periods indicated and then
analyzed by flow cytometry (10 000 events). (A) DJmwas measured in cells
incubated under control conditions for 4 h with H2O2. (B) MPTP opening
http://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLYH2O2 the DJm loss was highly pronounced (Fig. 2A).Recent studies have demonstrated that the loss in DJm
induced by H2O2 can be prevented by pretreatment with
E2 (AC Ronda, A Vasconsuelo & R Boland, submitted for
publication). Moreover, as shown in Fig. 2B, experiments
measuring calcein-AM by flow cytometry indicated that
the opening of the pore was observed even at 30 min of
treatment with H2O2 and increased in a time-dependent
fashion, persisting for 4 h. However, at 30 min of
treatment with H2O2, DJm loss was not evidenced
(data not presented).
These results are in general agreement with data
previously obtained using Janus Green stain, an indicator
of the status of the oxido-reduction mitochondrial system
(Lazarow & Cooperstein 1953, Ernster & Schatz 1981,
Ronda et al. 2010).was analyzed at different treatment intervals with H2O2 (30, 60, 180, and
240 min). Experiments were repeated at least three times with essentially
identical results. FL-1: FL-1 channel that detects green fluorescence.
Full colour version of this figure available via http://dx.doi.org/10.1530/
JOE-12-0486.
Published by Bioscientifica Ltd.
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As mentioned in the Introduction, in healthy cells Bax
exists as a monomer either in the cytosol or loosely
attached to the outer mitochondrial membrane. Upon
induction of apoptosis, the cytosolic Bax translocates to
mitochondria and is inserted into the organelle’s
membrane, affecting its function. To correlate the results
described above with the participation of Bax, cells were
treated with 0.5 mM H2O2 during different time inter-
vals. Immunocytochemistry studies were performed
using an anti-Bax polyclonal antibody (green fluor-
escence) and Mitotracker (red fluorescence). We observed
that H2O2 treatment induced time-dependent (1, 3, and
4 h) Bax translocation to mitochondria in C2C12 cells,
which was more evident after 3 h of apoptosis induction.
As shown in Fig. 3A (upper panel), control conditions
showed a fine-grained fluorescence, homogeneously
dispersed in the cytoplasm. However, in presence of
H2O2 the fluorescence appeared focalized in mito-
chondria (yellow fluorescence). These results were
corroborated by performing western blot assays (Fig.
3A, bottom panel). To evaluate the effect of E2 over Bax
translocation, cells were stained with Mitotracker and
then treated with 10K8 M E2 or vehicle 0.001% iso-
propanol (control) w120 min before induction of
apoptosis (0.5 mM H2O2, 4 h). Immunocytochemistry
studies wereperformed using ananti-Baxantibodyasbefore.
In presence of the hormone, the green fluorescence
appeareddiffuse inall thecytosolas inthecontrol condition,
showing inhibition of Bax translocation to mitochondriaFigure 3
E2 inhibits H2O2-induced Bax translocation to mitochondria in C2C12
skeletal myoblasts. (A) Cells were treated with 0.5 mM H2O2 for 1, 3, and
4 h. (Upper panel) Cells were preincubated with Mitotracker
(red fluorescence) and then with anti-Bax, and fluorophore-conjugated
secondary antibodies (green fluorescence) were used as described in
Materials and methods. In the control condition, Bax is visualized as
fine-grained fluorescence homogeneously dispersed in the cytoplasm
while H2O2 treatment induced its translocation to mitochondria (yellow
fluorescence). (Bottom panel) Mitochondrial and cytosolic fractions were
used to perform western blot assays and probed for Bax localization.
(B) Cells were incubated with vehicle (control) or 10K8 M E2 before the
addition of H2O2 for immunocytochemistry studies as described above.
Representative images are shown. Magnification 60!. (C) Lysates were
obtained following different treatments and then subjected to subcellular
fractionation. Enriched mitochondrial and cytosolic fractions were used to
perform western blots assays and probed for Bax translocation.
Experiments were repeated at least three times with essentially identical
results. Full colour version of this figure available via http://dx.doi.org/
10.1530/JOE-12-0486.
Published by Bioscientifica Ltd.
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respect to the control and #P!0.05 with respect to E2 120 min.
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Figure 5
E2 restores MnSOD expression in C2C12 skeletal myoblasts treated with
H2O2. C2C12 cells were incubated under different experimental conditions.
C and E2: vehicle or 10
K8 E2 for 6 h. H2O2: 0.5 mM H2O2 for 4 h. E2CH2O2:
10K8 E2 for 2 h followed by 0.5 mM H2O2 for 4 h in the presence of the
steroid, as indicated in Materials and methods. Lysates were used to probe
for the expression of MnSOD by western blot assays. The blots are
representative of three independent experiments with comparable results.
Densitometric quantification of blots is shown; averages GS.D. are given.
*P!0.05 with respect to the control and #P!0.05 with respect to H2O2.
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216 :3 338(Fig. 3B). We confirmed these results by performing western
blots assays using the same antibody (Fig. 3C).
E2 modulates MnSOD in C2C12 skeletal myoblasts cells
As it is known that ROS levels affect MPTP performance,
and that they are regulated in part by mitochondrial
MnSOD (Van Remmen et al. 2001), we investigated
whether E2 exerts any effects on this antioxidant mito-
chondrial enzyme. We evaluated MnSOD expression
levels in response to the hormone. C2C12 cell cultureshttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLYwere incubated with 10K8 M E2 during different timeintervals (40, 60, and 120 min) followed by measurement
of MnSOD protein expression by immunoblot analysis
of cell lysates. Figure 4A shows that MnSOD protein level
was increased by E2 time dependently (7G2, 34G4.7, and
122G16.8% over control after 40, 60, and 120 min
of treatment respectively). In addition, we observed
that in presence of 1 mM fulvestrant, an ER antagonist,
the E2-induced MnSOD expression was significantly
inhibited (107G14%). We also investigated the effects of
E2 on enzyme activity. To that end, C2C12 cells were
treated with the hormone as before and lysates were
centrifugated to obtain the mitochondrial fraction. Then,
the activity of MnSOD was evaluated using a commercially
available Superoxide Dismutase Assay Kit II as described in
Materials and methods. As shown in Fig. 4B, the steroid
increased MnSOD activity (45G1.7 and 48G1.1% above
the control after 60 and 120 min of treatment respect-
ively). Moreover, when cells were preincubated with
fulvestrant and then treated with the hormone, the
E2-induced increase in MnSOD activity was prevented
(47G0.6%). We also observed (Fig. 5) that H2O2 treatment
reduced the levels of MnSOD (61G4.6% with respect
to control), thus indicating that the enzyme couldPublished by Bioscientifica Ltd.
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deleterious effect over the mitochondrial enzyme.Discussion
Although the classical target of estrogens is the nucleus, it
has been demonstrated in the last years that E2 can act at
different cellular sites including mitochondria (reviewed
in Vasconsuelo et al. (2011)). In previous studies, we
showed that E2 abrogates H2O2-induced apoptosis in
skeletal muscle cells involving both ERa and ERb,
PI3K/Akt/Bad, HSP27, and MAPKs (Vasconsuelo et al.
2008, 2010, Ronda et al. 2010). Accordingly, a protective
effect of the steroid on mitochondria integrity was
evidenced, as cytochrome c release by H2O2 was inhibited
by E2 through ERb (Vasconsuelo et al. 2008). The data
obtained in this work, using the C2C12 murine skeletal
myoblasts line, deepen the knowledge of molecular
actions triggered by E2, which result in mitochondrial
protection. Although the exact nature of cytochrome
c release during apoptosis remains to be completely
understood, it is believed that multiple mechanisms
may coexist in a cell and the activation of one of them
under a certain condition may be influenced by several
factors such as the nature of the apoptotic inducer
(Gogvadze et al. 2006). In this work, by means of an
established method to evaluate MPTP opening with
calcein-AM/CoCl2 loaded cells, it was found that H2O2
treatment induced MPTP aperture. The participation of
Bcl-2 proteins, specifically Bax, should be taken into
consideration, as the present studies demonstrated that
H2O2 treatment induced its translocation to mito-
chondria. In mitochondria from other cell types, Bax
can interact with MPTP components: VDAC or ANT
(Marzo et al. 1998, Narita et al. 1998). Therefore, Bax may
regulate MPTP function via direct molecular interactions
with these pore components. Further investigations of
protein interactions are necessary to evaluate whether
these events occur in skeletal muscle cells in response to
H2O2 treatment. In this study it was shown that when
cells were preincubated with E2, both Bax translocation
to mitochondria and MPTP aperture were abolished.
These processes could be part of the molecular
mechanism activated by the hormone, resulting in
mitochondrial protection as a consequence of an
antiapoptotic effect.
It has been reported that during apoptosis, the
mitochondrial membrane potential (DJm) decreases
and that there exists a connection between the functionshttp://joe.endocrinology-journals.org  2013 Society for Endocrinology
DOI: 10.1530/JOE-12-0486 Printed in Great BritainPY ONLYof DJm and of MPTP (Armstrong 2006). However, thereare controversies about which event occurs initially,
wondering if membrane depolarization is the conse-
quence rather than the cause of pore opening. In the
current study, contributing with more data to elucidate
this unresolved subject, it was evidenced that opening of
MPTP is achieved before DJm loss in C2C12 skeletal
myoblasts cells. In this context, additional studies are
necessary to determine the exact point of action of Bcl-2
family members (e.g. Bax might interact with VDAC or
other MPTP protein components), regulating MPTP
opening and DJm loss.
We also showed that E2 modulates the mitochondrial
enzyme MnSOD, suggesting a possible role in E2 protective
action. ROS can activate the MPTP (Petronilli et al. 1994)
but cells are equipped with antioxidant enzymes that can
prevent these and other effects of ROS. We demonstrated
that the hormone was able to increase MnSOD protein
levels and accordingly its activity in skeletal muscle cells.
Therefore, it can be postulated a genomic rather than a
rapid effect of E2 at this level. Our results indicate that the
hormone prepares the cell to resist to an apoptotic
stimulus. H2O2 treatment reduced the levels of MnSOD
suggesting that this could be a factor contributing to
muscle apoptosis. Preincubation with E2 diminished the
loss of MnSOD in H2O2-treated C2C12 cells. In view that
the ER antagonist fulvestrant blocked the estrogen effects
on MnSOD in the muscle cell system, we propose that an
ER is involved in this antiapoptotic mechanism. Other
antioxidant enzymes such as catalase or glutathione
peroxidase could also mediate the protective effect.
Studies are currently in progress to elucidate whether the
hormone regulates these enzymes.
In conclusion, the results presented herein, linked to
our previously published data, demonstrate that physio-
logical levels of E2 regulate several muscle cell signaling
intermediates that by acting in concert, both at the
genomic and non-genomic level, exert antiapoptotic
effects in C2C12 skeletal myoblasts.
Finally, these studies are of relevance to skeletal
muscle physiology as C2C12 myoblasts resemble the
activated satellite cells that surround mature myofibers.
As differentiated adult skeletal muscle fibers have scarce
ability to repair and regenerate themselves when a cellular
injury exists, satellite cells have the capacity to proliferate
and differentiate, vital properties to repair the injured
tissue (Yoshida et al. 1998). In this context, satellite cells
and their response to stress such as oxidative stress are
important to mature skeletal muscle performance and
function. Of significance for our work, enhanced satellitePublished by Bioscientifica Ltd.
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